The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey
Abstract
Authors
E. Parali O. Ozdemir K. Bozkurt M. Demir B. Ince H. Kultursay G. Ongen Z. Ongen C. Deger B. Marmarali M.O. Ozel F. Sumer E. Tuna Z.S. Yilmaz